Exploring the Advantages of Ready-to-use Lipid-Based Gene Delivery for Gene-Modified Cell Therapy
On-Demand Webinar
Watch this webinar to explore a non-viral alternative for ex vivo transfection of immune and stem cells, designed to overcome the limitations of traditional gene delivery methods. Learn how innovative lipid-based gene delivery offers key advantages for gene-modified cell therapies (GMCTs), including simplicity of use, cost-efficiency, high efficacy and enhanced cell health and growth, compared to viral vectors and/or electroporation.
Case study data is presented detailing firsthand experience with the technology in a head-to-head comparison with electroporation for TRAC knockout in T cells, highlighting its ease of use and cost-efficiency, and potential to reshape the future of GMCT development.
What You Will Learn:
- Key advantages of lipid-based delivery approaches for ex vivo transfection of immune and stem cells, including accessibility, cost-efficiency and cell viability
- Real-world applications and benefits of lipid-based gene delivery versus traditional methods like electroporation and viral vectors
- Practical applications of non-viral delivery for gene-modified cell therapies including engineered T cells, NK cells and hematopoietic stem cells in key disease areas including cancer, autoimmune disease, and genetic disorders